https://lumosdiagnostics.com/ 2026-09-06 weekly 1.0 https://lumosdiagnostics.com/news/media 2026-09-06 daily 0.9 https://lumosdiagnostics.com/about/about-lumos 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/about/employment 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/about/team 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/contact 2026-08-21 monthly 0.6 https://lumosdiagnostics.com/home 2026-09-01 monthly 0.6 https://lumosdiagnostics.com/invest 2026-08-21 monthly 0.6 https://lumosdiagnostics.com/invest/announcements 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/news 2026-08-21 monthly 0.6 https://lumosdiagnostics.com/privacy-policy 2026-08-21 monthly 0.6 https://lumosdiagnostics.com/products 2026-08-21 monthly 0.6 https://lumosdiagnostics.com/products/febridx/rest-of-world 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/products/febridx/rest-of-world/amr 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/products/febridx/rest-of-world/how-to-use 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/products/febridx/rest-of-world/the-science 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/products/febridx/rest-of-world/tools 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/products/febridx/usa 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/products/febridx/usa/amr 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/products/febridx/usa/how-to-order 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/products/febridx/usa/how-to-use 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/products/febridx/usa/the-science 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/products/febridx/usa/tools 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/services 2026-08-21 monthly 0.6 https://lumosdiagnostics.com/services/app-cloud 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/services/assay-development 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/services/manufacturing 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/services/medical-affairs 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/services/quality-regulatory-affairs 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/services/readers 2026-09-03 monthly 0.6 https://lumosdiagnostics.com/news-item/replay-rebridx-us-launch-update 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/100-locations-and-growing-a-milestone-for-febridx-adoption 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-achieves-250-patient-milestone-in-febridx-paediatric-study 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/febridx-rollout-gains-momentum-with-43-new-wellstreet-locations 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/replay-umos-diagnostics-q3-fy26-investor-briefing 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-secures-new-contract-manufacturing-agreement-first-purchase-order-with-micro-pak 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-receives-largest-febridx-order-to-date-from-phase-scientific 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/fda-clia-waiver-for-febridx-unlocks-us1b-us-opportunity 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/replay-lumos-diagnostics-1h-fy26-investor-briefing 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-complete-1st-enrollment-milestone-for-paediatric-study 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/texas-aandm-university-health-services-adopts-febridx-in-student-medical-centers 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-commences-febridx-clia-waived-pediatric-study 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/proactive-interview-with-cfo-barrie-lambert 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-diagnostics-signs-second-anz-distribution-agreement-for-febridx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-fy25-results-investor-briefing 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-secures-follow-on-contract-with-aptatek-biosciences-for-development-of-pku-in-home-monitoring-device 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-and-barda-partner-to-undertake-an-additional-clinical-study-to-evaluate-use-of-febridxin-us-clia-waived-pediatric-settings 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/submission-of-clia-waiver-application-for-febridx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-diagnostics-partners-with-pro-spectus-to-accelerate-market-access-for-febridx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-signs-binding-term-sheet-for-adollar50-million-loan-facility 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-diagnostics-signs-exclusive-us-distribution-and-supply-agreement-with-phase-scientific-for-febridx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/video-investor-briefing-phase-scientific-agreement 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-diagnostics-reaches-50-recruitment-milestone-in-febridx-clia-waiver-clinical-study 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-secures-sixth-us-medicare-reimbursement-for-febridx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-secures-fifth-us-medicare-reimbursement-for-febridx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-advances-febridx-sales-with-imedical-purchase-order 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/q3-fy25-investor-briefing 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/may-2025-analyst-report-more-medicare-reimbursement-coverage-secured-for-febridx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/stockhead-biocurious-lumos-shines-a-light-on-the-post-pandemic-rapid-diagnosis-sector 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/quarterly-activity-statement-and-4c-period-ending-31-march-2025 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-secures-additional-us-medicare-reimbursement-coverage-for-febridx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-secures-us-medicare-reimbursement-coverage-for-febridx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/video-1h-fy25-results-investor-briefing 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-announces-expanded-scope-of-work-under-hologic-ffn-development-agreement 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/febridx-featured-in-australian-doctor 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/video-q2-fy25-investor-webinar 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-diagnostics-receives-cpt-pla-procedure-code-approval-for-febridxtm-in-the-us 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/nine-new-coverage 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-successfully-completes-retail-entitlement-offer 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-and-barda-to-partner-to-support-febridx-clia-waiver-study-and-application 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-awarded-national-contract-with-medigroup-for-febridx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-appoints-thermo-fisher-scientific-as-us-distributor-for-febridx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-successfully-completes-institutional-component-of-entitlement-offer 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/fy24-annual-report 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/q4-fy24-investor-webinar 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-diagnostics-quarterly-activity-statement-and-cash-flow-report-period-ended-30-june-2024 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/stockhead-air-supply-the-asx-medtechs-tackling-respiratory-illnesses 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/video-qanda-with-paul-kase-svp-commercial-operations 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/febridx-now-available-to-health-care-practitioners-in-belgium 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-diagnostics-expands-distribution-partnership-with-regional-health-care-group-henry-scheins-medical-business-in-australia-and-new-zealand-for-febridx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-receives-usdollar400k-phase-1-milestone-payment-from-hologic 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/new-febridx-study-journal-of-antimicrobial-chemotherapy 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-signs-major-development-and-ip-agreements-with-hologic 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/Quarterly-Interview-with-LDX-CEO-Doug-Ward 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/hologic-enables-maiden-net-free-cash-flow 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-to-exhibit-at-2024-urgent-care-convention 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/new-febridx-study-published-in-peer-reviewed-journal-infectious-diseases-and-clinical-microbiology 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-appoints-henry-schein-as-us-distributor-for-febridx-r 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/cbs-news-cdc-warns-overuse-of-antibiotics-may-cause-antimicrobial-resistant-infections 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/us-fda-grants-emergency-use-authorization-for-viradx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/usa-today-not-if-but-when-antibiotic-resistance-poses-existential-threat-for-modern-medicine 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-receives-us-fda-clearance-for-febriDx 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/lumos-diagnostics-appoints-doug-ward-as-ceo 2026-08-24 monthly 0.7 https://lumosdiagnostics.com/news-item/economic-evaluation-of-lumos-diagnostics-febridx-point-of-care-test-highlights-2-5-billion-in-potential-u-s-healthcare-cost-savings-annually 2026-08-24 monthly 0.7